Discovery of Highly Bioactive Peptides through Hierarchical Structural Information and Molecular Dynamics Simulations
Journal of Chemical Information and Modeling · 11.11.2024 · 64 (21) · 8164-8175
DOI: 10.1021/acs.jcim.4c01006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, online erschienen am 28.10.2024. Verfasst von Shu Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Artificial Intelligence Driven Drug Discovery, Faculty of Applied Science, Macao Polytechnic University, Macao SAR 999078, China. Hauptthemen laut MEDLINE: Molecular Dynamics Simulation, Peptides. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Beijing Normal University, National Natural Science Foundation of China, Macao Polytechnic University Foundation.
Abstract (Originalsprache)
Peptide drugs play an essential role in modern therapeutics, but the computational design of these molecules is hindered by several challenges. Traditional methods like molecular docking and molecular dynamics (MD) simulation, as well as recent deep learning approaches, often face limitations related to computational resource demands, complex binding affinity assessments, extensive data requirements, and poor model interpretability. Here, we introduce PepHiRe, an innovative methodology that utilizes the hierarchical structural information in peptide sequences and employs a novel strategy called Ladderpath, rooted in algorithmic information theory, to rapidly generate and enhance the efficiency and clarity of novel peptide design. We applied PepHiRe to develop BH3-like peptide inhibitors targeting myeloid cell leukemia-1, a protein associated with various cancers. By analyzing just eight known bioactive BH3 peptide sequences, PepHiRe effectively derived a hierarchy of subsequences used to create new BH3-like peptides. These peptides underwent screening through MD simulations, leading to the selection of five candidates for synthesis and subsequent in vitro testing. Experimental results demonstrated that these five peptides possess high inhibitory activity, with IC50 values ranging from 28.13 ± 7.93 to 167.42 ± 22.15 nM. Our study explores a white-box model driven technique and a structured screening pipeline for identifying and generating novel peptides with potential bioactivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre of Artificial Intelligence Driven Drug Discovery, Faculty of Applied Science, Macao Polytechnic University, Macao SAR 999078, China.
- Department of Systems Science, Faculty of Arts and Sciences, Beijing Normal University, Zhuhai 519087, China.
- International Academic Center of Complex Systems, Beijing Normal University, Zhuhai 519087, China.
- School of Systems Science, Beijing Normal University, Beijing 100875, China.
- Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
ORCID-Profile: Liuqing Chen, Yu Liu
Förderung
- Beijing Normal University
- National Natural Science Foundation of China
- Macao Polytechnic University Foundation
Zitieren
APA
Li, S., Peng, L., Chen, L., Que, L., Kang, W., Hu, X., Ma, J., Di, Z., & Liu, Y. (2024). Discovery of Highly Bioactive Peptides through Hierarchical Structural Information and Molecular Dynamics Simulations. Journal of Chemical Information and Modeling, 64(21), 8164-8175. https://doi.org/10.1021/acs.jcim.4c01006
Vancouver
Li S, Peng L, Chen L, Que L, Kang W, Hu X, et al. Discovery of Highly Bioactive Peptides through Hierarchical Structural Information and Molecular Dynamics Simulations. Journal of Chemical Information and Modeling. 2024;64(21):8164-8175. doi:10.1021/acs.jcim.4c01006
BibTeX
@article{Li2024,
author = {Li, Shu and Peng, Lu and Chen, Liuqing and Que, Linjie and Kang, Wenqingqing and Hu, Xiaojun and Ma, Jun and Di, Zengru and Liu, Yu},
title = {Discovery of Highly Bioactive Peptides through Hierarchical Structural Information and Molecular Dynamics Simulations},
journal = {Journal of Chemical Information and Modeling},
year = {2024},
volume = {64},
number = {21},
pages = {8164--8175},
doi = {10.1021/acs.jcim.4c01006}
}
EUVIMED